AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

About 2.7 million people in the U.S. live with inflammatory bowel diseases, which cause long-term inflammation in the ...

IBD flare-ups can affect your daily life. Ways to manage these flare-ups may include stress management, dietary changes, ...

The upward revision in Skyrizi guidance more than offsets the reduced outlook for Humira guidance. AbbVie now expects U.S.

A new study shows that a healthy, plant-based diet could reduce your risk of inflammatory bowel disease by 14%.

The research was conducted by the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES 21) consortium, ...

The research was conducted by the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES 21) consortium, a group of international IBD and public health experts led by Gilaad G.

Q2 2025 Earnings Call Transcript July 31, 2025 AbbVie Inc. beats earnings expectations. Reported EPS is $2.97, expectations ...

A new large-scale study has found that Americans born in 1990 face four times the risk of developing rectal cancer compared to those born in 1950, sounding alarms about rising early-onset ...

Hunter Renfrow is making a comeback with the Carolina Panthers after being cut by the Las Vegas Raiders in March 2024. He had ...

A recent study reveals a concerning rise in early-onset colorectal cancer, particularly among those born in 1990, who face a ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.